Jia Jie Biomedical Co., Ltd. Statistics
Jia Jie Biomedical Co., Ltd. (4109) Stock Statistics & Valuation Metrics
Total Valuation
Jia Jie Biomedical Co., Ltd. has a market cap or net worth of TWD 1.21B. The enterprise value is TWD 968.80M.
- Market Cap
- TWD 1.21B
- Enterprise Value
- TWD 968.80M
Share Statistics
Jia Jie Biomedical Co., Ltd. has 118,736,680 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 118,736,680
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Jia Jie Biomedical Co., Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 0.03%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 0.03%
- Return on Capital Employed (ROCE)
- 0.00
- Revenue Per Employee
- 7.24M
- Profits Per Employee
- 750.15K
- Employee Count
- 67
- Asset Turnover
- 0.26
- Inventory Turnover
- 12.11
Valuation Ratios
The current PE Ratio of Jia Jie Biomedical Co., Ltd. is 256.25. Jia Jie Biomedical Co., Ltd.’s PEG ratio is 0.47.
- PE Ratio
- 256.25
- PS Ratio
- 2.36
- PB Ratio
- 0.75
- Price to FCF
- -23.25
- Price to Operating Cash Flow
- 93.29
- PEG Ratio
- 0.47
Income Statement
In the last 12 months, Jia Jie Biomedical Co., Ltd. had revenue of 485.40M and earned 50.26M in profits. Earnings per share was 0.43.
- Revenue
- 485.40M
- Gross Profit
- 150.34M
- Operating Income
- 710.00K
- Pretax Income
- 59.86M
- Net Income
- 50.26M
- EBITDA
- 18.24M
- Earnings Per Share (EPS)
- 0.43
Cash Flow
In the last 12 months, operating cash flow was 13.04M and capital expenditures -65.39M, giving a free cash flow of -52.35M billion.
- Operating Cash Flow
- 13.04M
- Free Cash Flow
- -52.35M
- Free Cash Flow per Share
- -0.44
Dividends & Yields
Jia Jie Biomedical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 1.96%
- Dividend Per Share
- ―
- Dividend Yield
- 1.96%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -4.30%
- Earnings Yield
- 0.34%
Stock Price Statistics
- Beta
- 0.37
- 52-Week Price Change
- -36.14%
- 50-Day Moving Average
- 10.90
- 200-Day Moving Average
- 11.72
- Relative Strength Index (RSI)
- 29.59
- Average Volume (3m)
- 137.31K
Important Dates
Jia Jie Biomedical Co., Ltd. upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Aug 04, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Jia Jie Biomedical Co., Ltd. as a current ratio of 3.36, with Debt / Equity ratio of 3.15%
- Current Ratio
- 3.36
- Quick Ratio
- 3.20
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- -13.35
- Interest Coverage Ratio
- 2.56
Taxes
In the past 12 months, Jia Jie Biomedical Co., Ltd. has paid 7.75M in taxes.
- Income Tax
- 7.75M
- Effective Tax Rate
- 0.13
Enterprise Valuation
Jia Jie Biomedical Co., Ltd. EV to EBITDA ratio is 17.57, with an EV/FCF ratio of -20.33.
- EV to Sales
- 2.07
- EV to EBITDA
- 17.57
- EV to Free Cash Flow
- -20.33
- EV to Operating Cash Flow
- 81.62
Balance Sheet
Jia Jie Biomedical Co., Ltd. has TWD 500.33M in cash and marketable securities with TWD 87.85M in debt, giving a net cash position of TWD 412.48M billion.
- Cash & Marketable Securities
- TWD 500.33M
- Total Debt
- TWD 87.85M
- Net Cash
- TWD 412.48M
- Net Cash Per Share
- TWD 3.47
- Tangible Book Value Per Share
- TWD 13.33
Margins
Gross margin is 26.78%, with operating margin of 6.14%, and net profit margin of 0.81%.
- Gross Margin
- 26.78%
- Operating Margin
- 6.14%
- Pretax Margin
- 0.53%
- Net Profit Margin
- 0.81%
- EBITDA Margin
- 11.77%
- EBIT Margin
- 8.71%
Analyst Forecast
The average price target for Jia Jie Biomedical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 13.00%
- EPS Growth Forecast
- 902.22%
